Precigen, Inc. (PGEN): Price and Financial Metrics

Precigen, Inc. (PGEN): $1.42

0.04 (+2.54%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add PGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#293 of 360

in industry

PGEN Price/Volume Stats

Current price $1.42 52-week high $1.88
Prev. close $1.38 52-week low $0.84
Day low $1.39 Volume 237,633
Day high $1.45 Avg. volume 1,062,950
50-day MA $1.46 Dividend yield N/A
200-day MA $1.35 Market Cap 352.22M

PGEN Stock Price Chart Interactive Chart >


Precigen, Inc. (PGEN) Company Bio


Precigen, Inc. (formerly Intrexon Corporation) provides synthetic biology services. The Company designs and produces modular DNA control systems and applications for human therapeutics, protein production, industrial products, agricultural biotechnology, and animal sciences. The company was founded in 1998 and is based in Germantown, Maryland.


PGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

PGEN Latest Social Stream


Loading social stream, please wait...

View Full PGEN Social Stream

Latest PGEN News From Around the Web

Below are the latest news stories about PRECIGEN INC that investors may wish to consider to help them evaluate PGEN as an investment opportunity.

Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three years

Precigen, Inc. ( NASDAQ:PGEN ) shareholders should be happy to see the share price up 16% in the last month. But the...

Yahoo | December 27, 2023

Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will present a corporate and clinical overview at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 5:15 PM PT/8:15 PM ET in San Francisco, California.

Yahoo | December 18, 2023

5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains

These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.

Thomas Yeung on InvestorPlace | December 4, 2023

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit on Wednesday, December 6, 2023 at 3:00 PM ET.

Yahoo | November 29, 2023

3 Penny Stocks to Buy to Turn $1 into $100: November 2023

Are you looking for outsized gains for your portfolio.

Gabriel Osorio-Mazzilli on InvestorPlace | November 22, 2023

Read More 'PGEN' Stories Here

PGEN Price Returns

1-mo 1.79%
3-mo 2.16%
6-mo 27.93%
1-year 22.41%
3-year -82.40%
5-year -67.65%
YTD 5.97%
2023 -11.84%
2022 -59.03%
2021 -63.63%
2020 86.13%
2019 -16.21%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!